Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 260

    1.

    The transition from ductal carcinoma in situ to invasive breast cancer: the other side of the coin.

    Schnitt SJ.

    Breast Cancer Res. 2009;11(1):101. Epub 2009 Feb 27.

    PMID:
    19291276
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    2.

    Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma.

    Castro NP, Osório CA, Torres C, Bastos EP, Mourão-Neto M, Soares FA, Brentani HP, Carraro DM.

    Breast Cancer Res. 2008;10(5):R87. Epub 2008 Oct 17.

    PMID:
    18928525
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    3.

    Regulation of in situ to invasive breast carcinoma transition.

    Hu M, Yao J, Carroll DK, Weremowicz S, Chen H, Carrasco D, Richardson A, Violette S, Nikolskaya T, Nikolsky Y, Bauerlein EL, Hahn WC, Gelman RS, Allred C, Bissell MJ, Schnitt S, Polyak K.

    Cancer Cell. 2008 May;13(5):394-406.

    PMID:
    18455123
    [PubMed - indexed for MEDLINE]
    4.

    Breaking down barriers: the importance of the stromal microenvironment in acquiring invasiveness in young women's breast cancer.

    Schedin P, Borges V.

    Breast Cancer Res. 2009;11(2):102. Epub 2009 Mar 26.

    PMID:
    19344495
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    6.

    Detection of stromal invasion in breast cancer: the myoepithelial markers.

    Yaziji H, Gown AM, Sneige N.

    Adv Anat Pathol. 2000 Mar;7(2):100-9. Review.

    PMID:
    10721417
    [PubMed - indexed for MEDLINE]
    7.

    The natural history of ductal carcinoma in situ of the breast: a review.

    Erbas B, Provenzano E, Armes J, Gertig D.

    Breast Cancer Res Treat. 2006 May;97(2):135-44. Epub 2005 Dec 1. Review.

    PMID:
    16319971
    [PubMed - indexed for MEDLINE]
    8.

    Role of COX-2 in epithelial-stromal cell interactions and progression of ductal carcinoma in situ of the breast.

    Hu M, Peluffo G, Chen H, Gelman R, Schnitt S, Polyak K.

    Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3372-7. Epub 2009 Feb 13.

    PMID:
    19218449
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    9.

    Phenotypic alterations in ductal carcinoma in situ-associated myoepithelial cells: biologic and diagnostic implications.

    Hilson JB, Schnitt SJ, Collins LC.

    Am J Surg Pathol. 2009 Feb;33(2):227-32.

    PMID:
    18936688
    [PubMed - indexed for MEDLINE]
    10.

    Gene expression profiling of the tumor microenvironment during breast cancer progression.

    Ma XJ, Dahiya S, Richardson E, Erlander M, Sgroi DC.

    Breast Cancer Res. 2009;11(1):R7. Epub 2009 Feb 2.

    PMID:
    19187537
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    11.

    Cytological criteria for the diagnosis of intraductal hyperplasia, ductal carcinoma in situ, and invasive carcinoma of the breast.

    Bofin AM, Lydersen S, Hagmar BM.

    Diagn Cytopathol. 2004 Oct;31(4):207-15.

    PMID:
    15452908
    [PubMed - indexed for MEDLINE]
    12.

    Biology of ductal carcinoma in situ classification based on biologic potential.

    Tsikitis VL, Chung MA.

    Am J Clin Oncol. 2006 Jun;29(3):305-10. Review.

    PMID:
    16755185
    [PubMed - indexed for MEDLINE]
    13.

    Chromosomal alterations associated with the transition from in situ to invasive breast cancer.

    Ellsworth RE, Vertrees A, Love B, Hooke JA, Ellsworth DL, Shriver CD.

    Ann Surg Oncol. 2008 Sep;15(9):2519-25. Epub 2008 Jul 12.

    PMID:
    18622645
    [PubMed - indexed for MEDLINE]
    14.

    Mechanisms of disease: breast tumor pathogenesis and the role of the myoepithelial cell.

    Barsky SH, Karlin NJ.

    Nat Clin Pract Oncol. 2006 Mar;3(3):138-51. Review.

    PMID:
    16520804
    [PubMed - indexed for MEDLINE]
    15.

    The molecular journey from ductal carcinoma in situ to invasive breast cancer.

    Wiechmann L, Kuerer HM.

    Cancer. 2008 May 15;112(10):2130-42. Review.

    PMID:
    18383519
    [PubMed - indexed for MEDLINE]
    Free Article
    16.

    Loss of aurora A/STK15/BTAK overexpression correlates with transition of in situ to invasive ductal carcinoma of the breast.

    Hoque A, Carter J, Xia W, Hung MC, Sahin AA, Sen S, Lippman SM.

    Cancer Epidemiol Biomarkers Prev. 2003 Dec;12(12):1518-22.

    PMID:
    14693746
    [PubMed - indexed for MEDLINE]
    Free Article
    17.

    Ductal carcinoma in situ of the breast: diagnosis and management.

    Friedrich M, Felberbaum R, Krämer S, Axt-Fliedner R, Diedrich K.

    Onkologie. 2003 Dec;26(6):588-95. Review.

    PMID:
    14709936
    [PubMed - indexed for MEDLINE]
    18.

    Actin-rich (myoepithelial) cells in ductal carcinoma-in-situ of the breast.

    Bussolati G, Botta G, Gugliotta P.

    Virchows Arch B Cell Pathol Incl Mol Pathol. 1980;34(3):251-9.

    PMID:
    6108644
    [PubMed - indexed for MEDLINE]
    19.

    Dynamic stromal-epithelial interactions during progression of MCF10DCIS.com xenografts.

    Tait LR, Pauley RJ, Santner SJ, Heppner GH, Heng HH, Rak JW, Miller FR.

    Int J Cancer. 2007 May 15;120(10):2127-34.

    PMID:
    17266026
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk